Genoray Co., Ltd. (KOSDAQ:122310)
South Korea · Delayed Price · Currency is KRW 4,720.00
-10.00 (-0.21%)
At close: Apr 17, 2026
Genoray Revenue
In the year 2025, Genoray had annual revenue of 108.04B KRW with 0.99% growth. Genoray had revenue of 34.05B in the quarter ending December 31, 2025, with 18.40% growth.
Revenue
108.04B
Revenue Growth
+0.99%
P/S Ratio
0.53
Revenue / Employee
300.12M
Employees
360
Market Cap
57.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 108.04B | 1.06B | 0.99% |
| Dec 31, 2024 | 106.98B | 9.08B | 9.28% |
| Dec 31, 2023 | 97.90B | 15.29B | 18.51% |
| Dec 31, 2022 | 82.60B | 8.31B | 11.19% |
| Dec 31, 2021 | 74.29B | 12.60B | 20.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DRGEM | 102.75B |
| JPI Healthcare | 48.47B |
| CU Medical Systems | 48.22B |
| Hironic | 32.09B |
| Remed | 24.50B |
| Neofect | 16.05B |
| MEKICS CO., | 11.29B |
| Noul Co.,Ltd. | 5.12B |